The brain-specific activator p35 allows Cdk5 to escape inhibition by p27Kip1 in neurons.
- 16 April 1996
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 93 (8) , 3259-3263
- https://doi.org/10.1073/pnas.93.8.3259
Abstract
Cell cycle withdrawal in postmitotic cells involves cyclin-dependent kinase (Cdk) inhibitors that repress cell cycle Cdk activity. During mouse neurogenesis, cortical postmitotic neurons are shown here to accumulate high levels of the p27 Cdk inhibitor compared with their progenitor neuroblasts. Elevated p27 levels in staged embryo brain extracts correlate with p27 binding to Cdk2, and Cdk inactivation. Yet, Cdk5, which is associated with the noncyclin activator p35 in neurons, remains active in the presence of high p27 levels. Both in vitro and in vivo, p27 and related inhibitors can recognize a cyclin D-Cdk5 complex but not a p35-Cdk5 complex. The results indicate that the choice of activator determines the susceptibility of Cdk5 to p27 and related Cdk inhibitors, and thus its ability to act in postmitotic cells.Keywords
This publication has 35 references indexed in Scilit:
- Identification of the 23 kDa subunit of tau protein kinase II as a putative activator of cdk5 in bovine brainPublished by Wiley ,2001
- Inhibitors of mammalian G1 cyclin-dependent kinases.Genes & Development, 1995
- Cdk-activating kinase complex is a component of human transcription factor TFIIHNature, 1995
- Association of Cdk-activating kinase subunits with transcription factor TFIIHNature, 1995
- Cyclins and cancer II: Cyclin D and CDK inhibitors come of ageCell, 1994
- p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21Published by Elsevier ,1994
- p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest.Genes & Development, 1994
- p21 is a universal inhibitor of cyclin kinasesNature, 1993
- A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4Nature, 1993
- Universal control mechanism regulating onset of M-phaseNature, 1990